These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 17952653)

  • 61. Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: role of 5HT(1A) and CB2 receptors.
    Pazos MR; Mohammed N; Lafuente H; Santos M; Martínez-Pinilla E; Moreno E; Valdizan E; Romero J; Pazos A; Franco R; Hillard CJ; Alvarez FJ; Martínez-Orgado J
    Neuropharmacology; 2013 Aug; 71():282-91. PubMed ID: 23587650
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Potential Neuroprotective Effect of Cannabinoids in COVID-19 Patients.
    Cortes-Altamirano JL; Yáñez-Pizaña A; Reyes-Long S; Angélica GM; Bandala C; Bonilla-Jaime H; Alfaro-Rodríguez A
    Curr Top Med Chem; 2022; 22(16):1326-1345. PubMed ID: 35382723
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Plant-derived, synthetic and endogenous cannabinoids as neuroprotective agents. Non-psychoactive cannabinoids, 'entourage' compounds and inhibitors of N-acyl ethanolamine breakdown as therapeutic strategies to avoid pyschotropic effects.
    Fowler CJ
    Brain Res Brain Res Rev; 2003 Jan; 41(1):26-43. PubMed ID: 12505646
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Stimulated CB1 Cannabinoid Receptor Inducing Ischemic Tolerance and Protecting Neuron from Cerebral Ischemia.
    Zhuang Q; Dai C; Yang L; Wen H; Wang H; Jiang X; Zhang Y
    Cent Nerv Syst Agents Med Chem; 2017; 17(2):141-150. PubMed ID: 27142423
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Potential roles of (endo)cannabinoids in the treatment of glaucoma: from intraocular pressure control to neuroprotection.
    Nucci C; Bari M; Spanò A; Corasaniti M; Bagetta G; Maccarrone M; Morrone LA
    Prog Brain Res; 2008; 173():451-64. PubMed ID: 18929127
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington's disease.
    Sagredo O; Pazos MR; Satta V; Ramos JA; Pertwee RG; Fernández-Ruiz J
    J Neurosci Res; 2011 Sep; 89(9):1509-18. PubMed ID: 21674569
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cannabinoids.
    López-Rodríguez ML
    Mini Rev Med Chem; 2005 Jul; 5(7):607. PubMed ID: 16026306
    [No Abstract]   [Full Text] [Related]  

  • 68. The G protein-coupled receptor 55 ligand l-α-lysophosphatidylinositol exerts microglia-dependent neuroprotection after excitotoxic lesion.
    Kallendrusch S; Kremzow S; Nowicki M; Grabiec U; Winkelmann R; Benz A; Kraft R; Bechmann I; Dehghani F; Koch M
    Glia; 2013 Nov; 61(11):1822-31. PubMed ID: 24038453
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Microglial Phenotypes and Their Relationship to the Cannabinoid System: Therapeutic Implications for Parkinson's Disease.
    Kelly R; Joers V; Tansey MG; McKernan DP; Dowd E
    Molecules; 2020 Jan; 25(3):. PubMed ID: 31973235
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of a Sativex-Like Combination of Phytocannabinoids on Disease Progression in R6/2 Mice, an Experimental Model of Huntington's Disease.
    Valdeolivas S; Sagredo O; Delgado M; Pozo MA; Fernández-Ruiz J
    Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28333097
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Sex differences in Parkinson's disease and other movement disorders.
    Smith KM; Dahodwala N
    Exp Neurol; 2014 Sep; 259():44-56. PubMed ID: 24681088
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cannabinoids and Tremor Induced by Motor-related Disorders: Friend or Foe?
    Arjmand S; Vaziri Z; Behzadi M; Abbassian H; Stephens GJ; Shabani M
    Neurotherapeutics; 2015 Oct; 12(4):778-87. PubMed ID: 26152606
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cannabinoid receptor subtypes 1 and 2 mediate long-lasting neuroprotection and improve motor behavior deficits after transient focal cerebral ischemia.
    Schmidt W; Schäfer F; Striggow V; Fröhlich K; Striggow F
    Neuroscience; 2012 Dec; 227():313-26. PubMed ID: 23069763
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Neuroprotective strategies in Parkinson's disease : an update on progress.
    Mandel S; Grünblatt E; Riederer P; Gerlach M; Levites Y; Youdim MB
    CNS Drugs; 2003; 17(10):729-62. PubMed ID: 12873156
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cannabinoids and neuroprotection in CNS inflammatory disease.
    Jackson SJ; Diemel LT; Pryce G; Baker D
    J Neurol Sci; 2005 Jun; 233(1-2):21-5. PubMed ID: 15894331
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Synthetic and endogenous cannabinoids protect retinal neurons from AMPA excitotoxicity in vivo, via activation of CB1 receptors: Involvement of PI3K/Akt and MEK/ERK signaling pathways.
    Kokona D; Thermos K
    Exp Eye Res; 2015 Jul; 136():45-58. PubMed ID: 25989217
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Neuroprotection of Coenzyme Q10 in Neurodegenerative Diseases.
    Yang X; Zhang Y; Xu H; Luo X; Yu J; Liu J; Chang RC
    Curr Top Med Chem; 2016; 16(8):858-66. PubMed ID: 26311425
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Neuroprotection in Parkinson's disease and other neurodegenerative disorders: preclinical and clinical findings].
    Rákóczi K; Klivényi P; Vécsei L
    Ideggyogy Sz; 2009 Jan; 62(1-2):25-34. PubMed ID: 19248724
    [TBL] [Abstract][Full Text] [Related]  

  • 79. VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington's disease.
    Díaz-Alonso J; Paraíso-Luna J; Navarrete C; Del Río C; Cantarero I; Palomares B; Aguareles J; Fernández-Ruiz J; Bellido ML; Pollastro F; Appendino G; Calzado MA; Galve-Roperh I; Muñoz E
    Sci Rep; 2016 Jul; 6():29789. PubMed ID: 27430371
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Insight Into the Emerging Role of Striatal Neurotransmitters in the Pathophysiology of Parkinson's Disease and Huntington's Disease: A Review.
    Jamwal S; Kumar P
    Curr Neuropharmacol; 2019; 17(2):165-175. PubMed ID: 29512464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.